For the Inventor, By the Inventor

Enter assignee name

Biotie Therapies Corporation

USPTO Granted Patents = 28

CIPO Patents = 8

EPO Patents = 10

Forward Citations = 44

Loading Chart...

Loading Chart...

66 inventors (with patents filed for the assignee):

David Smith (10 out of 10 patents)

Markku Jalkanen (7 out of 16 patents)

Thomas R Malefyt (7 out of 21 patents)

4. Marjo Pihlavisto (7 out of 8 patents)

5. Zsolt Szakonyi (5 out of 6 patents)

6. Lesley Pickford (4 out of 4 patents)

7. Christopher G Salentine (3 out of 11 patents)

8. Auni Juhakoski (3 out of 3 patents)

9. Ferenc Fulop (3 out of 12 patents)

10. Laszlo Lazar (3 out of 4 patents)

11. Istvan Szatmari (3 out of 3 patents)

12. Ferenc Miklos (3 out of 3 patents)

13. Lorand Kiss (3 out of 3 patents)

14. Marta Palko (3 out of 3 patents)

15. Ulf Lindahl (3 out of 6 patents)

28 patents: Sort by Forward Citations

1. 10973784 - Compositions and methods for treating Alzheimer's disease and Parkinson's disease (2021-04-13),

2. 10653699 - Controlled-release tozadenant formulations (2020-05-19),

3. 10576148 - Use of VAP-1 inhibitors for treating fibrotic conditions (2020-03-03),

4. 10561638 - Methods for treating dependence (2020-02-18),

5. 10479771 - Pyridazinone and pyridone compounds (2019-11-19),

6. 10314798 - Compositions and methods for treating Alzheimer's disease and Parkinson's disease (2019-06-11),

7. 9815795 - Pyridazinone and pyridone compounds (2017-11-14),

8. 9795671 - Use of VAP-1 inhibitors for treating fibrotic conditions (2017-10-24),

9. 9371290 - Pyridazinone compounds (2016-06-21),

10. 8735576 - Benzothiazole derivatives (2014-05-27),

11. 8501938 - Benzothiazole derivatives (2013-08-06),

12. 8212044 - Benzothiazole derivatives (2012-07-03),

13. 8168785 - Benzothiazole derivatives (2012-05-01),

14. 8142783 - Methods of treating an inflammatory condition involving VAP-1-mediated adhesion with VAP-1-specific antibodies (2012-03-27),

15. 8119651 - Compositions useful especially for treatment or prevention of metabolic syndrome (2012-02-21),

Biotie Therapies Corporation is a pharmaceutical company that focuses on the development of innovative therapies for neurological and psychiatric diseases. The company is committed to improving the lives of patients through the discovery and commercialization of novel drugs. Biotie Therapies Corporation's research and development efforts are centered around developing treatments for diseases such as Parkinson's, Alzheimer's, and substance use disorders. With a dedication to scientific excellence, Biotie Therapies Corporation strives to make a positive impact on global healthcare.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

28 Patents

#7 in Turku

#121 in Finland

#22,563 in the World

Biotie Therapies Corporation

Forward Citations = 44

66 inventors:

David Smith (10 out of 10 patents)

Markku Jalkanen (7 out of 16 patents)

Thomas R Malefyt (7 out of 21 patents)

4. Marjo Pihlavisto (7 out of 8 patents)

5. Zsolt Szakonyi (5 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…